001 | 20252 | ||
005 | 20240619091942.0 | ||
024 | 7 | _ | |2 pmid |a pmid:22357152 |
024 | 7 | _ | |2 DOI |a 10.1016/j.biomaterials.2012.01.057 |
024 | 7 | _ | |2 WOS |a WOS:000302425400015 |
024 | 7 | _ | |2 MLZ |a Mangiapia20123770 |
037 | _ | _ | |a PreJuSER-20252 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 570 |
084 | _ | _ | |2 WoS |a Engineering, Biomedical |
084 | _ | _ | |2 WoS |a Materials Science, Biomaterials |
100 | 1 | _ | |0 P:(DE-HGF)0 |a Mangiapia, G. |b 0 |
245 | _ | _ | |a Ruthenium-based complex nanocarriers for cancer therapy |
260 | _ | _ | |a Amsterdam [u.a.] |b Elsevier Science |c 2012 |
300 | _ | _ | |a 3770 - 3782 |
336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a article |2 DRIVER |
440 | _ | 0 | |0 863 |a Biomaterials |v 33 |x 0142-9612 |y 14 |
500 | _ | _ | |a This work was supported by MIUR (PRIN 2008-prot. 20087K9A2J). The authors thank the Forschungszentrum Julich for provision of beam time. SANS experiments were supported by the European Commission, NMI3 contract RII3-CT-2003-505925. |
520 | _ | _ | |a A new organometallic ruthenium complex, named AziRu, along with three amphiphilic nucleoside-based ruthenium complexes, ToThyRu, HoThyRu and DoHuRu, incorporating AziRu in their skeleton, have been synthesized, stabilized in POPC phospholipid formulations and studied for their antineoplastic activity. Self-aggregation behavior of these complexes was investigated, showing that the three synthesized AziRu derivatives able to form liposomes and, under specific conditions, elongated micelles. The formulations prepared in POPC proved to be stable for months and showed high in vitro antiproliferative activity. The here described results open new scenarios in the design of innovative transition metal-based supramolecular systems for anticancer drugs vectorization. |
536 | _ | _ | |0 G:(DE-Juel1)FUEK505 |2 G:(DE-HGF) |x 0 |c FUEK505 |a BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung (FUEK505) |
536 | _ | _ | |0 G:(DE-HGF)POF2-544 |a 544 - In-house Research with PNI (POF2-544) |c POF2-544 |f POF II |x 1 |
588 | _ | _ | |a Dataset connected to Web of Science, Pubmed |
650 | _ | 2 | |2 MeSH |a Animals |
650 | _ | 2 | |2 MeSH |a Antineoplastic Agents: administration & dosage |
650 | _ | 2 | |2 MeSH |a Antineoplastic Agents: chemistry |
650 | _ | 2 | |2 MeSH |a Cell Line, Tumor |
650 | _ | 2 | |2 MeSH |a Cell Survival: drug effects |
650 | _ | 2 | |2 MeSH |a Drug Carriers |
650 | _ | 2 | |2 MeSH |a Drug Stability |
650 | _ | 2 | |2 MeSH |a Humans |
650 | _ | 2 | |2 MeSH |a Liposomes |
650 | _ | 2 | |2 MeSH |a Materials Testing |
650 | _ | 2 | |2 MeSH |a Microscopy, Fluorescence |
650 | _ | 2 | |2 MeSH |a Nanoparticles: administration & dosage |
650 | _ | 2 | |2 MeSH |a Nanoparticles: chemistry |
650 | _ | 2 | |2 MeSH |a Neoplasms: drug therapy |
650 | _ | 2 | |2 MeSH |a Organometallic Compounds: administration & dosage |
650 | _ | 2 | |2 MeSH |a Organometallic Compounds: chemistry |
650 | _ | 2 | |2 MeSH |a Rats |
650 | _ | 2 | |2 MeSH |a Ruthenium: administration & dosage |
650 | _ | 2 | |2 MeSH |a Ruthenium: chemistry |
650 | _ | 7 | |0 0 |2 NLM Chemicals |a Antineoplastic Agents |
650 | _ | 7 | |0 0 |2 NLM Chemicals |a Drug Carriers |
650 | _ | 7 | |0 0 |2 NLM Chemicals |a Liposomes |
650 | _ | 7 | |0 0 |2 NLM Chemicals |a Organometallic Compounds |
650 | _ | 7 | |0 7440-18-8 |2 NLM Chemicals |a Ruthenium |
650 | _ | 7 | |2 WoSType |a J |
650 | 2 | 7 | |a Biology |0 V:(DE-MLZ)SciArea-160 |2 V:(DE-HGF) |x 0 |
650 | 1 | 7 | |a Health and Life |0 V:(DE-MLZ)GC-130-2016 |2 V:(DE-HGF) |x 1 |
650 | 1 | 7 | |a Health and Life |0 V:(DE-MLZ)GC-130-1 |2 V:(DE-HGF) |x 0 |
653 | 2 | 0 | |2 Author |a Ruthenium-based complexes |
653 | 2 | 0 | |2 Author |a Antineoplastic agents |
653 | 2 | 0 | |2 Author |a Nanoaggregates |
653 | 2 | 0 | |2 Author |a Anti-proliferative activity |
693 | _ | _ | |0 EXP:(DE-MLZ)KWS2-20140101 |1 EXP:(DE-MLZ)FRMII-20140101 |5 EXP:(DE-MLZ)KWS2-20140101 |6 EXP:(DE-MLZ)NL3ao-20140101 |a Forschungs-Neutronenquelle Heinz Maier-Leibnitz |e KWS-2: Small angle scattering diffractometer |f NL3ao |x 0 |
700 | 1 | _ | |0 P:(DE-HGF)0 |a D'Errico, G. |b 1 |
700 | 1 | _ | |0 P:(DE-HGF)0 |a Simeone, L. |b 2 |
700 | 1 | _ | |0 P:(DE-HGF)0 |a Irace, C. |b 3 |
700 | 1 | _ | |0 P:(DE-Juel1)VDB4342 |a Radulescu, A. |b 4 |u FZJ |
700 | 1 | _ | |0 P:(DE-HGF)0 |a DiPascale, A. |b 5 |
700 | 1 | _ | |0 P:(DE-HGF)0 |a Colonna, A. |b 6 |
700 | 1 | _ | |0 P:(DE-HGF)0 |a Montesarchio, D. |b 7 |
700 | 1 | _ | |0 P:(DE-HGF)0 |a Paduano, L. |b 8 |
773 | _ | _ | |0 PERI:(DE-600)2004010-6 |a 10.1016/j.biomaterials.2012.01.057 |g Vol. 33, p. 3770 - 3782 |p 3770 - 3782 |q 33<3770 - 3782 |t Biomaterials |v 33 |x 0142-9612 |y 2012 |
856 | 7 | _ | |u http://dx.doi.org/10.1016/j.biomaterials.2012.01.057 |
909 | C | O | |o oai:juser.fz-juelich.de:20252 |p VDB:MLZ |p VDB |
913 | 2 | _ | |0 G:(DE-HGF)POF3-551 |1 G:(DE-HGF)POF3-550 |2 G:(DE-HGF)POF3-500 |a DE-HGF |b Key Technologies |l BioSoft Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |v Functional Macromolecules and Complexes |x 0 |
913 | 2 | _ | |0 G:(DE-HGF)POF3-623 |1 G:(DE-HGF)POF3-620 |2 G:(DE-HGF)POF3-600 |a DE-HGF |b Forschungsbereich Materie |l In-house research on the structure, dynamics and function of matter |v Neutrons for Research on Condensed Matter |x 1 |
913 | 1 | _ | |x 0 |v In-house Research with PNI |1 G:(DE-HGF)POF2-540 |0 G:(DE-HGF)POF2-544 |2 G:(DE-HGF)POF2-500 |a DE-HGF |b Struktur der Materie |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF2 |l Forschung mit Photonen, Neutronen, Ionen |
914 | 1 | _ | |y 2012 |
915 | _ | _ | |0 StatID:(DE-HGF)0010 |2 StatID |a JCR/ISI refereed |
915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |
915 | _ | _ | |0 StatID:(DE-HGF)0110 |2 StatID |a WoS |b Science Citation Index |
915 | _ | _ | |0 StatID:(DE-HGF)0111 |2 StatID |a WoS |b Science Citation Index Expanded |
915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |
915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Thomson Reuters Master Journal List |
915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |
915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |
915 | _ | _ | |0 StatID:(DE-HGF)0310 |2 StatID |a DBCoverage |b NCBI Molecular Biology Database |
915 | _ | _ | |0 StatID:(DE-HGF)0420 |2 StatID |a Nationallizenz |
915 | _ | _ | |0 StatID:(DE-HGF)1030 |2 StatID |a DBCoverage |b Current Contents - Life Sciences |
915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |
920 | 1 | _ | |0 I:(DE-Juel1)ICS-1-20110106 |g ICS |k ICS-1 |l Neutronenstreuung |x 0 |
920 | 1 | _ | |0 I:(DE-Juel1)JCNS-FRM-II-20110218 |k JCNS (München) ; Jülich Centre for Neutron Science JCNS (München) ; JCNS-FRM-II |l JCNS-FRM-II |x 1 |
920 | 1 | _ | |0 I:(DE-Juel1)JCNS-1-20110106 |g JCNS |k JCNS-1 |l Neutronenstreuung |x 2 |
970 | _ | _ | |a VDB:(DE-Juel1)135513 |
980 | _ | _ | |a VDB |
980 | _ | _ | |a ConvertedRecord |
980 | _ | _ | |a journal |
980 | _ | _ | |a I:(DE-Juel1)ICS-1-20110106 |
980 | _ | _ | |a I:(DE-Juel1)JCNS-FRM-II-20110218 |
980 | _ | _ | |a I:(DE-Juel1)JCNS-1-20110106 |
980 | _ | _ | |a UNRESTRICTED |
981 | _ | _ | |a I:(DE-Juel1)IBI-8-20200312 |
981 | _ | _ | |a I:(DE-Juel1)JCNS-1-20110106 |
981 | _ | _ | |a I:(DE-Juel1)JCNS-FRM-II-20110218 |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|